CP therapy (Carboplatin and Paclitaxel) for advansed malignant melanoma
Not Applicable
- Conditions
- malignant melanoma
- Registration Number
- JPRN-UMIN000004073
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survaival
- Secondary Outcome Measures
Name Time Method